cholinergic pathways and the limitations of inhaled therapeutics · 2019. 5. 16. · cholinergic...
TRANSCRIPT
Cholinergic Pathways and the limitations of inhaled therapeutics
Reinoud Gosens, PhD 06 Sept 2016
Department of Molecular Pharmacology University of Groningen
Groningen Research Institute for Asthma and COPD
• Anatomy of the airway cholinergic system.
• Role in bronchoconstriction.
• Pro-inflammatory nature of acetylcholine.
• Contribution to lung function impairment and exacerbations in COPD and asthma.
Goals
Sensory and motor units in the vagal nerve
Kistemaker et al
Sensory nerve
Motor nerve
0
20
40
60
80
100
0,5 1 2 4 8 16 31 62,5
Con
trac
tile
Res
pons
es
EFS (Hz)
Largeairways
Smallairways
Cholinergic neurons are expressed in large and small airways
Time
Sopi et al
Airway
Muscarinic Nicotinic
Acetylcholine
ChAT
Acetyl CoA + Choline
Acetylcholine: synthesis and mode of action
The airway cholinergic system
The output of the airway cholinergic system is increased by inflammation
Sensory nerve
Motor nerve
The airway cholinergic system may contribute to inflammation
Kistemaker and Gosens, Trends Pharmacol Sci (2015)
Tiotropium Aclidinium
Glycopyrronium
Umeclidinium
Long-acting muscarinic antagonists (LAMA)
Compound Dose Frequency Tiotropium 5 µg Once daily Aclidinium 400 µg Twice daily Glycopyrronium 50 µg Once daily Umeclidinium 125 µg Once daily
The Ideal Bronchodilator
Airflow
Quality of life
Exercise endurance
Immediate onset Long duration of action Safe
Exacerbations
Tashkin et al., NEJM (2004) 55:289-294
Long-term impact of tiotropium on lung function
Impact of LAMAs on COPD exacerbations
*p≤0.05; **p≤0.01; ***p≤0.001 Novartis, data on file
Kerwin et al., Eur Respir J (2012)
Impact of LAMAs on Asthma (lung function, exacerbations)
*p≤0.05; **p≤0.01; ***p≤0.001 Novartis, data on file
Severe asthma; on top of corticosteroids+ β2-agonists
Kerstjens, et al. NEJM (2012)
0
5
10
15
20
25
30
35
FEV
1 (%
rela
tive
chan
ge)
Bronchodilator treatment: reality vs. the ideal situation
• The airway cholinergic system is expressed in both large and small airways.
• Neuronal acetylcholine regulates bronchoconstriction with a predominant role for the M3 receptor.
• Inflammation can increase acetylcholine release which in turn may contribute to inflammation.
• Acetylcholine contributes to lung function impairment and exacerbations in COPD and asthma.
Summary - Conclusions